Company Analysis
Sign in

PRF Technologies Ltd. (PRFX)

Nasdaq: PRFX · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 2020
Full chart Alerts Compare
Grade3.8
◀ Past 5.3● Present 3.0▶ Future 3.4
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$17,000
Net income-$5.0M+65.6%
Earnings per share$-7.47+92.9%
Operating cash flow-$4.0M+68.7%
Cash$3.1M-26.2%
Debtn/a
Shareholders’ equity$8.5M+368.4%
Shares, diluted647,973+368.7%
Return on equity-58.8%
The recordfrom its filings
Filings in 202655
Newest filingNov 12 · 6-K
Annual reportMar 26, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted4
Filer categoryNon-accelerated filer
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
1819202122232425
As filed, in USD. Nothing here is a forecast.

News

Sep 24, 2026 · SEC EDGAR · Form SCHEDULE 13D
Activist holder notice
Open the filing on sec.gov
Sep 3, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton PRFX · research, not advice